Vascular endothelium and atherosclerosis

Handbook of Experimental Pharmacology

Volumn 176, Issue PART2, 2006, Pages 285-306

  Libby, P ^a   Aikawa, M ^a   Jain, M K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Immunity; Inflammation; Leukocytes; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CELL ADHESION MOLECULE; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC OXIDE; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL; ATHEROSCLEROSIS; DRUG EFFECT; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; REVIEW; THROMBOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; ASPIRIN; ATHEROSCLEROSIS; CELL ADHESION MOLECULES; CYCLOOXYGENASE INHIBITORS; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; NITRIC OXIDE; PROSTAGLANDINS I; THROMBOSIS;

EID: 34247869284     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-36028-x_9     Document Type: Article

References (68)

1. Aikawa M, Libby P (2004) The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 13:125-138 (Pubitemid 38470089)
2. Aikawa M, Sugiyama S, Hill C, Voglic S, Rabkin E, Fukumoto Y, Schoen F, Witztum JL, Libby P (2002) Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation 106:1390-1396 (Pubitemid 35013044)
3. Altschul R (1954) Endothelium; its development, morphology, function, and pathology. Macmillan, New York
4. Barger A, Beeuwkes IR, Lainey L, Silverman K (1984) Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med 310:175-177
5. Berliner JA,Watson AD (2005) A role for oxidized phospholipids in atherosclerosis. N Engl J Med 353:9-11 (Pubitemid 41007802)
6. Boisvert WA, Curtiss LK, Terkeltaub RA (2000) Interleukin-8 and its receptor CXCR2 in atherosclerosis. Immunol Res 21:129-137
7. Brogi E, Winkles J, Underwood R, Clinton S, Alberts G, Libby P (1993) Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and non-atherosclerotic arteries: association of acidic FGF with plaque microvessels and macrophages. J Clin Invest 92:2408-2418 (Pubitemid 23333549)
8. Cybulsky MI, Gimbrone Jr. M.A. (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-791
9. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107:1255-1262 (Pubitemid 32494542)
10. Davies MJ (1996) Stability and instability: the two faces of coronary atherosclerosis. The Paul DudleyWhite Lecture, 1995. Circulation 94:2013-2020 (Pubitemid 26349317)
11. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone MJ, Libby P (1995) The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 14: 1829-1836
12. Dekker RJ, Von Soest S, Fontijn RD, Salamanca S, de Groot PG, VanBavel E, Pannekoek H, Horrevoets AJG (2002) Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 100:1689-1698 (Pubitemid 34925146)
13. Delerive P,De Bosscher K, Besnard S,Vanden BergheW, Peters JM,Gonzalez FJ, Fruchart JC, Tedgui A,Haegeman G, Staels B (1999) Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talkwith transcription factors NF-kappaB and AP-1. J Biol Chem 274:32048-32054
14. Dollery CM, Libby P (2006) Atherosclerosis and proteinase activation. Cardiovasc Res 69:625-635 (Pubitemid 43139725)
15. Dollery CM, Owen CA, Sukhova GK, Krettek A, Shapiro SD, Libby P (2003) Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation 107:2829-2836 (Pubitemid 36705994)
16. Faggiotto A, Ross R, Harker L (1984) Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4:323-340 (Pubitemid 14092676)
17. GimbroneMAJr (1981)Vascular endotheliumand atherosclerosis. InMoore S (ed)Vascular injury and atherosclerosis. Marcel Dekker, New York, pp 25-52
18. GimbroneMA Jr, Cotran RS, Folkman J (1974) Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol 60:673-684
19. Griendling KK, Harrison DG (2001) Out, damned dot: studies of the NADPH oxidase in atherosclerosis. J Clin Invest 108:1423-1424 (Pubitemid 33091978)
20. GuL,OkadaY,ClintonS, GerardC, Sukhova G,LibbyP,RollinsB(1998) Absenceofmonocyte chemoattractant protein-1 reduces atherosclerosis in low-density lipoprotein-deficient mice. Mol Cell 2:275-281 (Pubitemid 128373654)
21. Haley KJ, Lilly CM, Yang JH, Feng Y, Kennedy SP, Turi TG, Thompson JF, Sukhova GK, Libby P, Lee RT (2000) Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102:2185-2189
22. Hazen SL, Hsu FF, Gaut JP, Crowley JR, Heinecke JW (1999) Modification of proteins and lipids by myeloperoxidase. Methods Enzymol 300:88-105 (Pubitemid 28500587)
23. Heinecke JW (2003) Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 91:12A-16A. (Pubitemid 36351458)
24. HennV, Slupsky JR,GrafeM,Anagnostopoulos I, ForsterR,Muller-Berghaus G,KroczekRA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594 (Pubitemid 28157601)
25. Jaffe EA, Nachmann RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2745-2756
26. Jain MK, Ridker PM (2005) Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 4:977-987
27. JorisT,Nunnari JJ,Krolikowski FJ,MajnoG(1983) Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am J Pathol 113:341-358 (Pubitemid 14215141)
28. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R (2003) Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349:2316-2325 (Pubitemid 37509739)
29. Krauss RM (2005) Nutrition and cardiovascular disease. In Zipes DP, Libby P, Bonow RO, Braunwald E (eds) Braunwald's heart disease: a textbook of cardiovascular medicine, vol 1. Elsevier Saunders, Philadelphia, pp 1047-1056
30. Kumar A, Lin Z, Senbanerjee S, Jain MK (2005) Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases. Mol Cell Biol 25:5893-5903 (Pubitemid 40946546)
31. Lesnik P,Haskell CA, Charo IF (2003) Decreased atherosclerosis in CX3CR1/ mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111:333-340 (Pubitemid 36182209)
32. Li H, Cybulsky MI, Gimbrone Jr. M.A. , Libby P (1993) An atherogenic diet rapidly induces VCAM-1, a cytokine regulatable mononuclear leukocyte adhesion molecule, in rabbit endothelium. Arterioscler Thromb 13:197-204 (Pubitemid 23056792)
33. Libby P (1987) The active roles of cells of the blood vessel wall in health and disease. Mol Aspects Med 9:499-567
34. Libby P (1990) Inflammatory andimmune mechanisms in atherogenesis. In Leaf A,Weber P (eds) Atherosclerosis reviews, vol 21. Raven Press, New York, pp 79-89
35. Libby P, Aikawa M (2002) Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 8:1257-1262 (Pubitemid 35373557)
36. Libby P, Simon DI (2001) Inflammation and thrombosis: the clot thickens. Circulation 103:1718-1720 (Pubitemid 32291406)
37. Libby P, Theroux P (2005) Pathophysiology of coronary artery disease. Circulation 111: 3481-3488 (Pubitemid 40923403)
38. Libby P, Egan D, Skarlatos S (1997) Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 96:4095-4103
39. Libby P, Ganz P, Schoen FJ, Lee RT (2000) The vascular biology of the acute coronary syndromes. In Topol EJ (ed) Acute coronary syndromes. Marcel Dekker, New York, pp 33-57
40. Lin Z, Kumar A, Senbanerjee S, Staniszewski K, Parmar K, Vaughan DE, Gimbrone Jr. M.A. , Balasubramanian V, Garcia-Cardena G, Jain MK (2005) Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 96:e48-e57
41. Marx N, Sukhova GK, Collins T, Libby P, Plutzky J (1999) PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 99:3125-3131 (Pubitemid 29289077)
42. Marx N, Libby P, Plutzky J (2001) Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk? J Cardiovasc Risk 8:203-210 (Pubitemid 32803674)
43. Matsushita K,Morrell CN, Cambien B, Yang SX, Yamakuchi M, Bao C, Hara MR, Quick RA, CaoW, O'Rourke B, Lowenstein JM, Pevsner J,Wagner DD, Lowenstein CJ (2003) Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell 115:139-150 (Pubitemid 37329578)
44. Moulton KS, Heller E, Konerding MA, Flynn E, PalinskiW, Folkman J (1999) Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99:1726-1732 (Pubitemid 29162486)
45. Nagel T, Resnick N, Dewey CF Jr, GimbroneMA Jr (1999) Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler Thromb Vasc Biol 19:1825-1834 (Pubitemid 29379911)
46. O'Brien K, Allen M, McDonald T, Chait A, Harlan J, Fishbein D, McCarty J, Ferguson M Hudkins K, Benjamin C, Lobb R, Alpers C (1993) Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92:945-951 (Pubitemid 23262418)
47. Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone Jr. M.A. , Garcia-Cardena G (2005) Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 280:26714-26719 (Pubitemid 41040703)
48. Parmar KM, Larman HB,Dai G, Zhang Y,Wang ET, Moorthy SN, Kratz JR, Lin Z, JainMK, Gimbrone MA, Garcia-Cardena G (2006) Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 116:49-58 (Pubitemid 43121790)
49. Peng HB, Libby P, Liao JK (1995) Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 270:14214-14219
50. Peters W, Charo IF (2001) Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons fromknockout mice. Curr Opin Lipidol 12:175-180 (Pubitemid 32242925)
51. Poole JCF, Florey HW (1958) Changes in the endothelium of the aorta and the behavior of macrophages in experimental atheroma of rabbits. J Pathol Bacteriol 75:245-253
52. Rajavashisth T, Qiao JH, Tripathi S, Tripathi J, Mishra N, Hua M,Wang XP, Loussararian A, Clinton S, Libby P, Lusis A (1998) Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 101:2702-2710 (Pubitemid 28294579)
53. RajavashisthTB, Liao JK,Galis ZS,Tripathi S, Laufs U, Tripathi J, Chai NN,XuXP, Jovinge S, Shah PK, Libby P (1999) Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression ofmembrane type 1-matrix metalloproteinase. J Biol Chem 274:11924-11929
54. Rikitake Y, Liao JK (2005) Rho GTPases, statins, and nitric oxide. Circ Res 97:1232-1235
55. Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis (part I). N Engl J Med 295:369-377
56. SchonbeckU, Libby P (2004) Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 109:II18-II26 (Pubitemid 38724152)
57. Sen-Banerjee S,Mir S, Lin Z, Hamik A, Atkins GB, Das H, Banerjee P, Kumar A, JainMK (2005) Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 112:720-726 (Pubitemid 41099052)
58. SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, Feinberg MW, Chen Z, Simon DI, Luscinskas FW, Michel TM, Gimbrone Jr. M.A. , Garcia-Cardena G, Jain MK (2004) KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199:1305-1315 (Pubitemid 38685723)
59. Shaw G (1911) The doctor's dilemma. Penguin Books
60. Baltimore Smith JD, Trogan E, GinsbergM,Grigaux C, Tian J,MiyataM(1995) Decreased atherosclerosis in mice deficient in bothmacrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A 92:8264-8268
61. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P (2001) Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158:879-891 (Pubitemid 32221781)
62. Sugiyama S, Kugiyama K, Aikawa M, Nakamura S, Ogawa H, Libby P (2004) Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 24:1309-1314 (Pubitemid 38880026)
63. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA (2005) A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437:426-431 (Pubitemid 41613506)
64. vanderWalAC,Becker AE, vander LoosCM,DasPK(1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44 (Pubitemid 24026469)
65. Vaughan DE (2005) PAI-1 and atherothrombosis. J Thromb Haemost 3:1879-1883 (Pubitemid 41716575)
66. Virmani R, Burke AP, Farb A, Kolodgie FD (2002) Pathology of the unstable plaque. Prog Cardiovasc Dis 44:349-356 (Pubitemid 34535156)
67. Wagner DD (2005) New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol 25:1321-1324 (Pubitemid 40923346)
68. YamawakiH, Pan S, Lee RT, Berk BC (2005) Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 115: 733-738 (Pubitemid 40322249)